Allergy and Immunology · Boston, MA
NPI
1063495562
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
100 Blossom Street, Cox 201
Boston, MA, 02114
Phone (617) 726-3850
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
977 services
Medicare patients, 2024
188
Average age 70
Drug cost, 2024
$8.4M
584 prescriptions
Company payments, 2025
$13K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aleena Banerji was code 95018 (test - miscellaneous), 155 times for 14 patients. In total Aleena Banerji billed 977 services in 30 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95018 Test - Miscellaneous | Office | 155 | 14 | $18.08 | $2,802 |
| 99214 Office E&M - Established | Office | 102 | 95 | $98.70 | $10K |
| 95117 Treatment - Miscellaneous | Office | 59 | 27 | $10.30 | $608 |
| 95076 Test - Miscellaneous | Office | 55 | 47 | $101.64 | $5,590 |
| 99204 Office E&M - New | Office | 17 | 17 | $132.29 | $2,249 |
| 99215 Office E&M - Established | Office | 14 | 12 | $153.95 | $2,155 |
| 94010 Pulmonary Function Testing | Office | 13 | 12 | $21.80 | $283 |
By year: 2022 $44K for 1,346 services; 2023 $37K for 1,351 services; 2024 $33K for 977 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aleena Banerji prescribed most often to Medicare patients was Dupixent Syringe (Dupilumab), with 89 prescriptions and refills. In total Aleena Banerji wrote 584 Medicare prescriptions that cost $8.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Syringe Dupilumab | 89 | 101 | Under 11 | $384K |
| Takhzyro Lanadelumab-Flyo | 72 | 81 | Under 11 | $3.1M |
| Icatibant Icatibant Acetate | 64 | 64 | Under 11 | $776K |
| Montelukast Sodium Generic | 54 | 135 | 17 | $725 |
| Dupixent Pen Dupilumab | 24 | 29 | Under 11 | $102K |
| Azelastine Hcl Generic | 24 | 56 | Under 11 | $1,297 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 23 | 32 | 14 | $870 |
| Fluticasone Propionate Generic | 22 | 63 | Under 11 | $391 |
| Ipratropium Bromide Generic | 20 | 51 | Under 11 | $1,328 |
| Berinert C1 Esterase Inhibitor | 16 | 16 | Under 11 | $3.0M |
| Arnuity Ellipta Fluticasone Furoate | 16 | 26 | Under 11 | $6,049 |
| Epinephrine Generic | 15 | 15 | 12 | $2,159 |
| Haegarda C1 Esterase Inhibitor | 12 | 12 | Under 11 | $531K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 12 | 28 | Under 11 | $2,175 |
Brand drugs: 335 claims; generic drugs: 249 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aleena Banerji $13K ($13K in general payments such as food, travel and fees) from 5 companies. The largest payer was CSL Behring with $8,687.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.